Saving changes...

Done

Error

The HIV Patient Management Simulator: Translating Optimal Treatment Strategies into Practice via a Virtual Clinical Training Environment

The HIV Patient Management Simulator: Translating Optimal Treatment Strategies into Practice via a Virtual Clinical Training Environment

The HIV Patient Management Simulator: Translating Optimal Treatment Strategies into Practice via a Virtual Clinical Training Environment

Eric S. Daar, MD And Richard A. Elion, MD
Eric S. Daar, MD And Richard A. Elion, MD
on behalf of Postgraduate Healthcare Education, LLC

FREE
FREE
FREE

FREE
FREE
FREE

null FREE
FREE
FREE
null FREE
FREE
FREE
Normal Price: FREE FREE

Review:

Launch date: 13 Mar 2017
Expiry Date:

Last updated: 15 Mar 2017

Reference: 172107

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

You have null days left.

Description

Highly effective antiretroviral therapy (ART) has transformed HIV from a rapidly deteriorating condition to a complex, chronic condition, with individuals now expecting to live a normal lifespan. With longer survival, patients will be exposed to antiretroviral agents for decades. Therefore, maximizing the safety and tolerability of therapies, as well as preventing resistance is a high priority. Significant progress has been made toward simplified, single-tablet regimens, optimizing the long-term safety and tolerability of therapy. Despite these advances, clinicians face challenges when selecting and maintaining therapy. In this interactive activity, expert faculty will use a case-based approach to discuss various aspects of HIV management, including optimal starting regimens for treatment-naïve patients, as well as the role of switching therapy in treatment-experienced patients. They also will integrate updated guideline recommendations and evidence from recent clinical trials to identify best practices in the management of HIV.

Objectives

Objectives
Upon successful completion of this educational activity, physicians should be better able to:

-Implement initial HIV treatment strategies that reflect important patient characteristics, including age, medical work-up, comorbidities, and potential DDIs in accordance with evidence-based treatment guidelines.
-Review the impact of proper adherence to HIV therapy in preventing the emergence of resistance and optimizing treatment response.
-Use simplified HIV treatment regimens that reflect patient preference and optimize adherence in both the initial and post-failure settings.
-Examine the resistance profiles of available and emerging HIV treatment regimens.
-Identify virally-suppressed patients who may benefit from alteration to their HIV treatment.
-Utilize knowledge of effective HIV switching therapies and NRTI-sparing regimens when altering therapy in virally-suppressed patients.

Upon successful completion of this educational activity, nurses should be better able to:

-Review the impact of proper adherence to HIV therapy in preventing the emergence of resistance and optimizing treatment response.
-Examine the resistance profiles of available and emerging HIV treatment regimens.
-Identify virally-suppressed patients who may benefit from alteration to their HIV treatment.

Upon successful completion of this educational activity, pharmacists should be better able to:

-Implement initial HIV treatment strategies that reflect important patient characteristics, including age, medical work-up, comorbidities, and potential DDIs in accordance with evidence-based treatment guidelines.
-Review the impact of proper adherence to HIV therapy in preventing the emergence of resistance and optimizing treatment response.
-Use simplified HIV treatment regimens that reflect patient preference and optimize adherence in both the initial and post-failure settings.
-Examine the resistance profiles of available and emerging HIV treatment regimens.
-Identify virally-suppressed patients who may benefit from alteration to their HIV treatment.
-Utilize knowledge of effective HIV switching therapies and NRTI-sparing regimens when altering therapy in virally-suppressed patients.
Eric S. Daar, MD And Richard A. Elion, MD

Author Information Play Video Bio

Eric S. Daar, MD And Richard A. Elion, MD
on behalf of Postgraduate Healthcare Education, LLC

Eric S. Daar, MD Chief, Division of HIV Medicine Harbor-UCLA Medical Center Professor of Medicine David Geffen School of Medicine at UCLA Torrance, CA. Richard A. Elion, MD Associate Clinical Professor of Medicine George Washington University School of Medicine Co-Director, DC Dept of Health STD Research Program Washington, DC

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Pharmacy Education (ACPE)
  • 2.00 Hours -
    Exam Pass Rate: 75
    -
    Reference: 0482-9999-16-009-H02-P

Faculty and Disclosures

Additional Contributors

null

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error